Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Dimethylformamide → 3',5'-o-Bis-tert-butyldimethylsilyl-2'-deoxycytidine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Dimethylformamide | HCID 6228 | — |
| 반응물 | Deoxycytidine | HCID 13711 | — |
| 반응물 | tert-Butyldimethylsilyl chloride | HCID 28928 | — |
| 용매 | Methanol | HCID 887 | — |
| 생성물 | 3',5'-o-Bis-tert-butyldimethylsilyl-2'-deoxycytidine | HCID 131728726 | — |
반응 단계
2′-deoxycytidine dC (2.85 g, 12.54 mmol), imidiazole (6.49 g, 95.31 mmol), and TBSCl (7.18 g, 47.65 mmol) were added to anhydrous DMF (27 mL) and stirred at room temperature overnight under a N2 atmosphere. Methanol (20 mL) was added, and the mixture was stirred for 30 minutes and then concentrated in vacuo. Ethyl acetate (60 mL) and water (60 mL) were then added. The organic layer was separated and washed twice with water (20 mL), and the combined aqueous layer was extracted with ethyl acetate (20 mL). The combined organic layer was dried with Na2SO4, concentrated in vacuo, and purified by silica gel chromatography to give 3′,5′-O-bis-tert-butyldimethylsilyl-2′-deoxycytidine dC.01 (4.79 g, 84%) as a white foam.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07897737B2 |
| 출처 데이터셋 | uspto-grants-2011_03 |
| ORD ID | ord-55f76d26021948b5b4db730e8061adb4 |
| 출처 메모 | uspto-grants-2011_03 |